# Iridex Corp: filings

IRIX · Nasdaq · CIK 1006045 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jan 3

Pages: [Overview](/companies/irix.md) · [Financials](/companies/irix/financials.md) · [Filings](/companies/irix/filings.md) · [Insiders](/companies/irix/insiders.md)

## Reports and events: 309 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 449, 8-K 195, 10-Q 53, 3 26, SC 13G/A 22, 10-K 18, DEF 14A 18, 4/A 16, DEFA14A 16, SC 13G 13, SD 13, UPLOAD 13, S-8 9, ARS 8, CORRESP 8, SC 13D/A 8, 8-K/A 6, SC 13D 5, SC TO-I/A 4, 424B5 3, EFFECT 3, S-3 3, 10-K/A 2, 10-Q/A 2, 144 2, 424B3 2, PRE 14A 2, SC TO-I 2, 424B4 1, D 1, D/A 1, DEFR14A 1, NT 10-Q 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-02 | 20:20 ET | [8-K](/filings/0001193125-26-380229.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-26-380229 |
| 2026-08-18 | 20:54 ET | [10-Q](/filings/0001193125-26-355641.md) | Quarterly report, period 2026-07-04 | 0001193125-26-355641 |
| 2026-08-18 | 20:51 ET | [8-K](/filings/0001193125-26-355635.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-355635 |
| 2026-07-16 | 10:01 ET | [8-K](/filings/0001193125-26-305344.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-305344 |
| 2026-07-13 | 21:49 ET | [SCHEDULE 13D/A](/filings/0002064835-26-000078.md) | Ownership report, active investor, amended | 0002064835-26-000078 |
| 2026-06-18 | 20:14 ET | [8-K](/filings/0001193125-26-275883.md) | 8.01 Other events | 0001193125-26-275883 |
| 2026-05-19 | 20:16 ET | [10-Q](/filings/0001193125-26-230789.md) | Quarterly report, period 2026-04-04 | 0001193125-26-230789 |
| 2026-05-19 | 20:13 ET | [8-K](/filings/0001193125-26-230774.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-230774 |
| 2026-04-24 | 20:05 ET | [DEF 14A](/filings/0002077096-26-000092.md) | Proxy statement, period 2026-06-12 | 0002077096-26-000092 |
| 2026-04-02 | 20:20 ET | [10-K](/filings/0001193125-26-140194.md) | Annual report, period 2026-01-03 | 0001193125-26-140194 |
| 2026-03-26 | 20:22 ET | [8-K](/filings/0001193125-26-126323.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-126323 |
| 2026-03-13 | 20:16 ET | [8-K](/filings/0001193125-26-106190.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-106190 |
| 2026-01-12 | 14:11 ET | [8-K](/filings/0001193125-26-009912.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-009912 |
| 2026-01-08 | 21:28 ET | [SCHEDULE 13D](/filings/0002097627-26-000007.md) | Ownership report, active investor | 0002097627-26-000007 |
| 2025-12-11 | 15:16 ET | [8-K](/filings/0001193125-25-315298.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-315298 |
| 2025-11-12 | 21:25 ET | [10-Q](/filings/0001193125-25-277712.md) | Quarterly report, period 2025-09-27 | 0001193125-25-277712 |
| 2025-11-12 | 21:12 ET | [8-K](/filings/0001193125-25-277598.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-277598 |
| 2025-09-09 | 20:22 ET | [8-K](/filings/0001193125-25-199190.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-199190 |
| 2025-08-12 | 20:28 ET | [10-Q](/filings/0000950170-25-107375.md) | Quarterly report, period 2025-06-28 | 0000950170-25-107375 |
| 2025-08-12 | 20:17 ET | [8-K](/filings/0000950170-25-107345.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-107345 |
| 2025-06-13 | 20:38 ET | [8-K](/filings/0000950170-25-086292.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-086292 |
| 2025-05-22 | 20:18 ET | [8-K](/filings/0000950170-25-076352.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-076352 |
| 2025-05-20 | 21:26 ET | [8-K](/filings/0001174947-25-000809.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001174947-25-000809 |
| 2025-05-13 | 20:43 ET | [10-Q](/filings/0000950170-25-070469.md) | Quarterly report, period 2025-03-29 | 0000950170-25-070469 |
| 2025-05-13 | 20:16 ET | [8-K](/filings/0000950170-25-070385.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070385 |
| 2025-04-28 | 20:11 ET | [DEF 14A](/filings/0001174947-25-000633.md) | Proxy statement, period 2025-06-11 | 0001174947-25-000633 |
| 2025-04-14 | 20:13 ET | [8-K](/filings/0000950170-25-053714.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-053714 |
| 2025-04-08 | 20:31 ET | [8-K](/filings/0001193125-25-075760.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-075760 |
| 2025-04-03 | 21:02 ET | [8-K](/filings/0001193125-25-072447.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-072447 |
| 2025-03-27 | 20:24 ET | [10-K](/filings/0000950170-25-046107.md) | Annual report, period 2024-12-28 | 0000950170-25-046107 |
| 2025-03-27 | 20:12 ET | [8-K](/filings/0000950170-25-046076.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-046076 |
| 2025-03-20 | 21:39 ET | [8-K](/filings/0000950170-25-042190.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-042190 |
| 2025-01-14 | 18:13 ET | [8-K](/filings/0000950170-25-005194.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-005194 |
| 2024-11-26 | 00:16 ET | [8-K/A](/filings/0000950170-24-130699.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-130699 |
| 2024-11-26 | 00:13 ET | [8-K](/filings/0000950170-24-130698.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-130698 |
| 2024-11-13 | 22:20 ET | [8-K](/filings/0000950170-24-126507.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-126507 |
| 2024-11-12 | 21:35 ET | [10-Q](/filings/0000950170-24-125541.md) | Quarterly report, period 2024-09-28 | 0000950170-24-125541 |
| 2024-11-12 | 21:19 ET | [8-K](/filings/0000950170-24-125464.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125464 |
| 2024-10-03 | 21:04 ET | [8-K](/filings/0000950170-24-112474.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-112474 |
| 2024-09-06 | 10:09 ET | [8-K](/filings/0000950170-24-104222.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-104222 |
| 2024-08-08 | 20:31 ET | [10-Q](/filings/0000950170-24-094090.md) | Quarterly report, period 2024-06-29 | 0000950170-24-094090 |
| 2024-08-08 | 20:11 ET | [8-K](/filings/0000950170-24-093966.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-093966 |
| 2024-08-05 | 13:25 ET | [8-K](/filings/0000950170-24-090371.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-090371 |
| 2024-07-03 | 20:16 ET | [8-K](/filings/0001193125-24-175053.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-24-175053 |
| 2024-06-21 | 21:31 ET | [8-K](/filings/0000950170-24-075755.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-24-075755 |
| 2024-05-24 | 20:11 ET | [8-K](/filings/0000950170-24-064595.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-064595 |
| 2024-05-14 | 21:07 ET | [10-Q](/filings/0000950170-24-059771.md) | Quarterly report, period 2024-03-30 | 0000950170-24-059771 |
| 2024-05-14 | 20:28 ET | [8-K](/filings/0000950170-24-059624.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-059624 |
| 2024-04-29 | 21:01 ET | [DEF 14A](/filings/0001174947-24-000612.md) | Proxy statement, period 2024-06-18 | 0001174947-24-000612 |
| 2024-03-29 | 20:13 ET | [10-K](/filings/0000950170-24-038650.md) | Annual report, period 2023-12-30 | 0000950170-24-038650 |

Page 1 of 7. [Older](/companies/irix/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.